HDLの機能低下が“危険なプラーク”と関連することを解明 −新規測定法(ILG法)で⼼⾎管リスクの可視化に成功−

ad

2026-04-16 東京科学大学

本研究は、東京科学大学の研究チームが、HDL(善玉コレステロール)の「機能低下」が動脈硬化における危険なプラーク形成と関連することを明らかにした成果である。独自の簡便測定法ILG法により、HDLのコレステロール引き抜き能(CEC)を臨床で評価可能とし、CECが低い患者ほど破綻リスクの高い脂質性プラークを有することを実証した。従来のLDLやHDL濃度では捉えられなかった「残余リスク」を可視化できる点が重要であり、心筋梗塞などの予測精度向上に寄与する。今後は臨床現場での普及により、心血管疾患の予防・早期発見への応用が期待される。

HDLの機能低下が“危険なプラーク”と関連することを解明 −新規測定法(ILG法)で⼼⾎管リスクの可視化に成功−
図1. 本研究成果の概要

<関連情報>

光干渉断層撮影法による動脈硬化性病変と、固定化リポソーム結合ゲルビーズ法によるコレステロール排出能との関係 Relationship of atherosclerotic lesion by optical coherence tomography with cholesterol efflux capacity by immobilized liposome-bound gel beads method

Tsunehiro Miyakoshi ∙ Yuna Horiuchi ∙ Makoto Araki ∙ … ∙ Minoru Tozuka ∙ Tetsuo Sasano ∙ Ryunosuke Ohkawa
Atherosclerosis  Published:April 2, 2026
DOI:https://doi.org/10.1016/j.atherosclerosis.2026.120724

Highlights

  • CEC measured by ILG method is positively associated with the abundance of apolipoprotein E-containing HDL.
  • CEC values measured by the ILG method are lower in patients with large lipid-rich plaque than in those without.
  • The ILG assay can evaluate HDL quality, supporting its usefulness for cardiovascular disease risk assessment and prognosis.

Abstract

Background and aims

Cholesterol efflux capacity (CEC) is robust biomarker for atherosclerotic cardiovascular disease (ASCVD). However, cell-based CEC assays require complex procedures that limit clinical use. The immobilized liposome-bound gel beads (ILG) method, a newly developed cell-free CEC assay, demonstrates sufficient performance for clinical application. This study investigated the clinical significance of CEC measured by the ILG method in relation to HDL subclasses and coronary artery plaque characteristics.

Methods

We analyzed CEC and HDL parameters, including the ratio of apolipoprotein E (apoE)-HDL-C to HDL-C (%apoE) and HDL3-C/HDL2-C, in 61 patients who underwent coronary angiography or percutaneous coronary intervention. Coronary artery plaques were assessed by optical coherence tomography (OCT). A large lipid-rich plaque was defined as lipid length >5 mm and lipid arc >180°.

Results

CEC correlated positively with HDL-C and %apoE. Among the patients, 26 (42.6%) exhibited large lipid-rich plaques on OCT. Univariable analysis showed that CEC was significantly lower in patients with large lipid-rich plaques compared to those without. While this association did not reach statistical significance after multivariable adjustment (p = 0.109), the addition of CEC to traditional risk factors improved the model’s explanatory power (Nagelkerke R2: 0.346 to 0.381) and discriminatory ability (AUC: 0.775 to 0.805) for large lipid-rich plaques.

Conclusions

CEC measured using the ILG method reflects HDL subclass features and is associated with the burden of lipid-rich coronary artery plaques. These findings suggest the significance of CEC evaluated using the ILG method, supporting its potential for enhanced ASCVD risk assessment and further clinical applications.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました